# Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers

> **NCT01764685** · PHASE2 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 4 (actual)

## Conditions studied

- Heavy Drinking
- HIV
- Alcohol Dependence

## Interventions

- **DRUG:** Topiramate
- **BEHAVIORAL:** Medical Management
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01764685
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** We terminated the study due to problems recruiting alcoholic subjects with HIV.
- **Last updated:** 2016-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764685, "Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01764685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*